DE60234103D1 - Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine - Google Patents

Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine

Info

Publication number
DE60234103D1
DE60234103D1 DE60234103T DE60234103T DE60234103D1 DE 60234103 D1 DE60234103 D1 DE 60234103D1 DE 60234103 T DE60234103 T DE 60234103T DE 60234103 T DE60234103 T DE 60234103T DE 60234103 D1 DE60234103 D1 DE 60234103D1
Authority
DE
Germany
Prior art keywords
protein
repair
control
growth
gastrokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234103T
Other languages
German (de)
English (en)
Inventor
Gary F Toback
Terrence E Martin
Margaret Walsh-Reitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Original Assignee
University of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25234151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60234103(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Chicago filed Critical University of Chicago
Application granted granted Critical
Publication of DE60234103D1 publication Critical patent/DE60234103D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60234103T 2001-03-29 2002-03-29 Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine Expired - Lifetime DE60234103D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/821,726 US6734289B2 (en) 2001-03-29 2001-03-29 Gastrokines and derived peptides including inhibitors
PCT/US2002/009885 WO2002078640A2 (en) 2001-03-29 2002-03-29 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

Publications (1)

Publication Number Publication Date
DE60234103D1 true DE60234103D1 (de) 2009-12-03

Family

ID=25234151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234103T Expired - Lifetime DE60234103D1 (de) 2001-03-29 2002-03-29 Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine

Country Status (10)

Country Link
US (4) US6734289B2 (enExample)
EP (2) EP1415154B1 (enExample)
JP (3) JP4281947B2 (enExample)
AT (1) ATE446510T1 (enExample)
AU (2) AU2002303199B2 (enExample)
CA (2) CA2442635A1 (enExample)
DE (1) DE60234103D1 (enExample)
ES (1) ES2332882T3 (enExample)
MX (2) MXPA03008855A (enExample)
WO (2) WO2002092758A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734289B2 (en) * 2001-03-29 2004-05-11 The University Of Chicago Gastrokines and derived peptides including inhibitors
US7629317B2 (en) 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
DE102004047968A1 (de) * 2004-10-01 2006-04-06 B.R.A.H.M.S Ag Bestimmung von Gastrokine 1 (GKN1) als Biomarker für Entzündungen und Infektionen
AU2006244080C1 (en) * 2005-05-10 2012-02-02 The University Of Chicago Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis
MX2007013982A (es) * 2005-05-10 2008-03-13 Univ Chicago Uso de peptidos derivados del factor de crecimiento amp-18 para el tratamiento de la mucositis.
US8017576B2 (en) * 2005-05-10 2011-09-13 The University Of Chicago Methods and compositions to treat mucositis
ES2474573T3 (es) 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
EP2082674A1 (en) 2008-01-22 2009-07-29 Trelleborg Building Systems AB Waterproof sealing profile
EP2254464B1 (en) * 2008-02-18 2017-01-04 Medimetrics Personalized Drug Delivery B.V. Administration of drugs to a patient
US9957316B2 (en) 2012-12-19 2018-05-01 Lumen Bio Llc Weight loss by inhibition of gastrokine
WO2018141969A1 (en) * 2017-02-06 2018-08-09 Biotempt B.V. Peptide modulators of the interaction between human c-peptide and human elastin receptor for therapeutic use
KR102590757B1 (ko) * 2020-12-11 2023-10-17 가톨릭대학교 산학협력단 GKN1(Gastrokine 1) 특이적 항체 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476922A (en) 1987-06-24 1995-12-19 Arch Development Corporation Methods and compositions for the preparation and use of autocrine growth factors
US5135856A (en) 1987-06-24 1992-08-04 Arch Development Corp. Production of autocrine growth factors
US5102870A (en) 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
JP2938129B2 (ja) 1989-05-02 1999-08-23 武田薬品工業株式会社 虚血性腎疾患の予防・治療剤
US5644026A (en) * 1994-05-03 1997-07-01 La Jolla Cancer Research Foundation Epitaxin, a cell motility factor
JPH08231413A (ja) 1994-12-29 1996-09-10 Mochida Pharmaceut Co Ltd 臓器障害に基づく疾患の予防・治療剤
JP3859710B2 (ja) 1995-04-21 2006-12-20 三菱化学株式会社 虚血性疾患の予防及び／又は治療剤
AU6229098A (en) 1997-02-21 1998-09-09 Takara Shuzo Co., Ltd. Cancer-associated genes
US20030083461A1 (en) * 1997-06-16 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU8824098A (en) * 1997-08-06 1999-03-01 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP1090118A2 (en) 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
BR0008188A (pt) 1999-01-21 2002-02-13 Metamorphix Inc Inibidores de fator de diferenciação de crescimento e usos para os mesmos
CA2373915A1 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
JP2004522402A (ja) * 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
US7629317B2 (en) 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
US6734289B2 (en) * 2001-03-29 2004-05-11 The University Of Chicago Gastrokines and derived peptides including inhibitors
US8017576B2 (en) 2005-05-10 2011-09-13 The University Of Chicago Methods and compositions to treat mucositis

Also Published As

Publication number Publication date
CA2442684A1 (en) 2002-10-10
EP1423409A4 (en) 2005-12-07
WO2002092758A8 (en) 2003-02-20
CA2442635A1 (en) 2002-11-21
EP1415154A2 (en) 2004-05-06
JP4281947B2 (ja) 2009-06-17
AU2002258663B2 (en) 2008-02-21
US6734289B2 (en) 2004-05-11
AU2002303199B2 (en) 2008-03-13
ATE446510T1 (de) 2009-11-15
EP1423409A2 (en) 2004-06-02
EP1415154B1 (en) 2009-10-21
US7557083B2 (en) 2009-07-07
US8791068B2 (en) 2014-07-29
US20050054564A1 (en) 2005-03-10
US20050065328A1 (en) 2005-03-24
EP1415154A4 (en) 2004-12-22
WO2002078640A3 (en) 2004-03-04
ES2332882T3 (es) 2010-02-15
CA2442684C (en) 2013-11-19
JP2004532037A (ja) 2004-10-21
WO2002092758A3 (en) 2004-04-01
MXPA03008855A (es) 2004-12-06
JP4295516B2 (ja) 2009-07-15
US20130086701A1 (en) 2013-04-04
JP2007217422A (ja) 2007-08-30
WO2002092758A2 (en) 2002-11-21
US8278269B2 (en) 2012-10-02
WO2002092758A9 (en) 2004-06-24
JP2004537284A (ja) 2004-12-16
WO2002078640A2 (en) 2002-10-10
MXPA03008861A (es) 2004-10-15
US20030017548A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
RU2008115678A (ru) Пептиды, способные связываться с трансформирующим фактором роста бета 1 (tgf-бета 1)
DE60234103D1 (de) Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine
UA90657C2 (ru) Ловушки vegf и их терапевтические применения
JP2005520490A5 (enExample)
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
EP2258383A3 (en) Antigenic peptides derived from telomerase
NZ514887A (en) IBD-associated microbial antigens and methods of using same
EP1595547A3 (en) Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure
WO2002044320A3 (en) Human elongase genes and uses thereof
JP2006506942A5 (enExample)
WO2007018619A3 (en) Chimeric therapeutic agents
JP2008521795A5 (enExample)
WO2000037487A8 (de) INHIBITOREN DES INTEGRINS αvβ¿6?
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
JP2008541776A5 (enExample)
JP2004537284A5 (enExample)
JP2004532037A5 (enExample)
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
WO2003038061A3 (en) Ehrlichia disulfide bond formation proteins and uses thereof
WO2001053324A8 (en) Novel haptotactic peptides
ATE366810T1 (de) Menschliche p51-gene und deren genprodukte
DE60121735D1 (de) Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition